Genome-scale genetic screening identifies PRMT1 as a critical vulnerability in castration-resistant prostate cancer. (October 2020) - Tang, S.; Metaferia, N.; Nogueira, M.; Gelbard, M.; Alaiwi, S. Abou; Seo, J.H.; Hwang, J.; Strathdee, C.; Baca, S.; Li, J.; Abuhammad, S.; Zhang, X.; et al.